Kuhlmann SL, Arolt V, Haverkamp W, et al. - Researchers examined coronary heart disease (CHD) patients for the prevalence, treatment rates, prognosis, and management need of clinical and subclinical depression according to the American Heart Association recommendations and the National Institute for Health and Care Excellence guideline “Depression in Adults with a Chronic Physical Health Problem”. At 2 German university clinics, they recruited 1,024 patients (19% women) between 2012 and 2014; of these, 12% presented with clinical depression (depressive disorder) and 45% with subclinical depression [Patient Health Questionnaire (PHQ-9) score ≥ 5] at baseline. Among those with clinical depression, 46% reported receipt of treatment at least once during 12 months; 26% were on continuous treatment during follow-up. For the 12-months mortality, depressive disorder and depressive symptoms were significant risk factor-adjusted predictors. Persistence of depressive symptoms was noted in 85% of the clinically depressed and in 47% of the subclinically depressed patients. According to current recommendations, depression management may be required in 29% of all CHD patients within 1 year. Findings thereby highlights the necessity for improved recognition, referral, and continuous and enhanced clinical management of depression in CHD patients.